Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial

Désirée van der Heijde, In Ho Song, Aileen L. Pangan, Atul Deodhar, Filip van den Bosch, Walter P. Maksymowych, Tae Hwan Kim, Mitsumasa Kishimoto, Andrea Everding, Yunxia Sui, Xin Wang, Alvina D. Chu, Joachim Sieper

Research output: Contribution to journal › Article › peer-review

216 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences